
|Articles|February 3, 2005
Study may explain why prostate tumor cells become resistant to hormone therapy
Certain mutations in the androgen receptor protein appear to cause advanced and invasive prostate cancer, at least in a mouse model, according to a recent study in the Proceedings of the National Academy of Sciences (2005; 102:1151-6).
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves lutetium Lu 177 vipivotide tetraxetan for PSMA-positive mHSPC
2
Laura Bukavina, MD, and Gabriela Díaz, MD, on the rise of young-onset bladder cancer
3
BOND-003 Cohort C: Efficacy Results
4
Individualizing androgen pathway therapy in mCSPC
5








